adenovirus-5 encoding human adenylyl cyclase type 6
Gene therapyexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT00787059)
Timeline
Indications
Studied for
Mechanism of action
- Adenylate cyclase type 6Supplementation
ADCY6 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad5.hac6
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03360448 | Phase 3 | Sep 30, 2018 | Renova Therapeutics |
| NCT00787059 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2010 | Minneapolis Heart Institute, National Heart, Lung, and Blood Institute (NHLBI), Northwestern University, Renova Therapeutics, University of California, San Diego, University of Utah, University of Vermont, University of Wisconsin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Renova Therapeutics | For profit | 2 | 1 | 2 | 2010 |
| Minneapolis Heart Institute | Academic/Hospital | 1 | 0 | 1 | 2010 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2010 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of California, San Diego | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Vermont | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2010 |
8 organizations
Page 1 / 1